Initiating Insulin Therapy in Type 2 Diabetes

2005557 citationsJournal Articlebronze Open Access

Authors

Philip Raskin · The University of Texas Southwestern Medical Center

Elsie Allen · Novo Nordisk (United States)

Priscilla Hollander · Baylor University Medical Center

Andrew Lewin · National Research Institute

Robert A. Gabbay · Penn State Milton S. Hershey Medical Center

Peter Hu · Novo Nordisk (United States)

Bruce W. Bode

Abstract

In subjects with type 2 diabetes poorly controlled on OADs, initiating insulin therapy with twice-daily BIAsp 70/30 was more effective in achieving HbA(1c) targets than once-daily glargine, especially in subjects with HbA(1c) >8.5%.

Topics & Keywords

Diabetes Treatment and Management Diabetes Management and Research Metabolism, Diabetes, and Cancer

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Diabetes Care

Volume 28, Issue 2, pp. 260-265

DOI: 10.2337/diacare.28.2.260

Field-Weighted Citation Impact: 38.49